Tagged with

BSN Medical Mexico When you joined BSN Medical 3 years ago, what was the roadmap set in place for the growth and development of the company? Which opportunities did the company see in Mexico? From very early on, the major opportunity BSN Medical saw in Mexico was the manufacturing possibilities. The production facility…

P&G Singapore Innovation Center (SgIC) Why did P&G decide to set up the center in Singapore? There are several reasons why P&G decided on Singapore. First, we wanted to reach more consumers, particularly in emerging markets; Singapore is very central to that. From Singapore we can reach 2/3 of the world’s population within a 6…

Spar Todopromo Mexico In 2011, Todopromo decided to join forces with Spar, an American company specialized in merchandising and points of sale solutions. After remaining for many years as a self-run company, how did you experience this new joint venture? It has been great and we are proud to be part of a…

CECyC Pharma Mexico With the new drug registration laws that were announced in 2005, was CECyC Pharma initiated as result of this new law, or pre-emptively because you saw that the market was due to change? We started operations in 2005 as an authorized third party bioequivalence and clinical trials center. Companies like…

UCB - Belgium UCB was founded in 1928 by Mr Emmanuel Janssen in Belgium, what spirit would you say its founder left behind and what core values unique to the company were you asked to perpetuate? Having been with the company for the past five years, it quickly became clear to me that…

BRASS Biomedical Research and Support Services Pte Ltd. is an NUS University spin-off that has been around for more than 14 years; last year the company name was changed to BRASS. Why was this decision taken and what is the new image that Brass wants to project to the industry? We…

Array   After just six months in the country, Novartis Australia’s new Managing Director offers his perspectives on the Australian pharmaceutical market and healthcare system, his company’s commitment to R&D, and Australia’s competitiveness for clinical trials in the Asian context. You arrived in July 2012 after working in different positions for…

Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…

Eli Lilly BeLux Since 1969, Eli Lilly & Company has been investing in Belgium. Can you give our readers a brief overview of the company’s history here and highlight some of your most notable achievements in your 4 years as Managing Director? Eli Lilly & Company is a global leading American pharmaceutical company…

Baker & Mckenzie Mexico The regulatory framework in Mexico is in constant change, and pharmaceutical com-panies are struggling to comply. What sort of challenges are companies facing when deal-ing with COFEPRIS and what must be achieved? Permanent legal uncertainty and lack of transparency are the main challenges to re-solve. The first step would be…

Novo Nordisk - Australia Can you start by commenting on the state of diabetes in Australia at present? According to 2011 statistics nearly one million Australians have diabetes and about half of those are not aware that they have the condition. Australia is ranked 7th in the world in terms of prevalence of type…

Merck Sharp & Dohme Austria You have been the head of MSD’s Austrian operations since April 2009. Can you start by telling our readers about the evolution of the affiliate since the merger with Schering Plough? I have been with MSD Austria since before the merger, I started in early 2009 when the merger had…